Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant

1999485 citationsJournal Articlebronze Open Access

Authors

Daniel Martín · Emory University

Baruch D. Kuppermann · University of California, Irvine

Richard A. Wolitz · Kaiser Permanente San Francisco Medical Center

Alan G. Palestine · Georgetown University

Hong Li

Charles A. Robinson

Abstract

In patients with AIDS and cytomegalovirus retinitis, oral ganciclovir in conjunction with a ganciclovir implant reduces the incidence of new cytomegalovirus disease and delays progression of the retinitis. Treatment with oral or intravenous ganciclovir also reduces the risk of Kaposi's sarcoma.

Topics & Keywords

Cytomegalovirus and herpesvirus research Herpesvirus Infections and Treatments Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 340, Issue 14, pp. 1063-1070

DOI: 10.1056/nejm199904083401402

Field-Weighted Citation Impact: 24.88